Franzoi Maria Alice

Very happy that our study on socioeconomic inequalities in quality of life (QoL) for patients with early breast cancer (EBC) from the CANTO Study is finally out at @JCO_ASCO. ascopubs.org/doi/10.1200/JCO… 👇🏼👇🏼👇🏼👇🏼👇🏼👇🏼👇🏼👇🏼👇🏼👇🏼 🔎Setting: • ~5900 women with EBC • Treated in multiple French🇫🇷 institutions • QoL assessment (EORTC-QLQ-C30 and BR23) at diagnosis, Year 1, and Year 2 • Socioeconomic status (SES) indicators: financial difficulties, income, education • Covariates: age, comorbidities, stage, detailed treatment characteristics • Country with UHC and equal access to treatment Main Findings: • Pre-existing SES inequalities in QoL widen in the 2 years after diagnosis. • Independent of age, stage at diagnosis, and received treatment. Conclusions: • The QoL burden of EBC diagnosis and treatment is heavier in women with lower SES, • Irrespective of received treatment and disease severity • UHC and equal access are not enough to prevent inequality widening. • SES-adapted interventions are needed to, at least, prevent the widening of QoL inequalities following diagnosis and primary treatment of EBC. This work wouldn't be possible without the participants in the CANTO Study, brilliantly led by @ines_vazluis (@GR_SurvOnc). Thank you to all who greatly contributed at @unige_en @UNIGEnews @hug_ge @DOncologie (@iguessous, @silviast9) and @GustaveRoussy @GroupeUnicancer @Inserm (@AliceFranzoi, @dimeglio_anto, @ajrsferreira, @FAndreMD), and especially @GwennM11 who supervised the project.